11-118436539-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM1PM2PM5BP4

The NM_001197104.2(KMT2A):​c.27C>A​(p.Phe9Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F9C) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KMT2A
NM_001197104.2 missense

Scores

5
4
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.28

Publications

0 publications found
Variant links:
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
  • Wiedemann-Steiner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM1
In a mutagenesis_site Loss of interaction with MEN1. (size 0) in uniprot entity KMT2A_HUMAN
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr11-118436538-T-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2637324.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.32909724).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2ANM_001197104.2 linkc.27C>A p.Phe9Leu missense_variant Exon 1 of 36 ENST00000534358.8 NP_001184033.1 Q03164-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2AENST00000534358.8 linkc.27C>A p.Phe9Leu missense_variant Exon 1 of 36 1 NM_001197104.2 ENSP00000436786.2 Q03164-3
ENSG00000285827ENST00000648261.1 linkc.-798-32236C>A intron_variant Intron 1 of 6 ENSP00000498126.1 A0A3B3ITZ1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
1094702
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
520620
African (AFR)
AF:
0.00
AC:
0
AN:
23216
American (AMR)
AF:
0.00
AC:
0
AN:
12818
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13284
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27038
South Asian (SAS)
AF:
0.00
AC:
0
AN:
22222
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33670
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3664
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
916162
Other (OTH)
AF:
0.00
AC:
0
AN:
42628
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jul 08, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.27C>A (p.F9L) alteration is located in exon 1 (coding exon 1) of the KMT2A gene. This alteration results from a C to A substitution at nucleotide position 27, causing the phenylalanine (F) at amino acid position 9 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.040
CADD
Uncertain
25
DANN
Benign
0.97
DEOGEN2
Benign
0.24
.;T;.;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.047
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.71
T;T;T;T
M_CAP
Pathogenic
0.95
D
MetaRNN
Benign
0.33
T;T;T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Benign
0.97
L;L;.;L
PhyloP100
2.3
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-1.7
N;N;N;.
REVEL
Uncertain
0.39
Sift
Pathogenic
0.0
D;D;D;.
Sift4G
Uncertain
0.052
T;T;D;.
Polyphen
0.23
.;B;B;.
Vest4
0.32
MutPred
0.26
Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);
MVP
0.85
MPC
0.93
ClinPred
0.76
D
GERP RS
3.6
PromoterAI
-0.091
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
3.2
Varity_R
0.89
gMVP
0.47
Mutation Taster
=67/33
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782207243; hg19: chr11-118307254; COSMIC: COSV63292741; API